Potent inhibition of protein tyrosine phosphatases by copper complexes with multi-benzimidazole derivatives

A series of copper complexes with multi-benzimidazole derivatives, including mono- and di-nuclear, were synthesized and characterized by Fourier transform IR spectroscopy, UV–Vis spectroscopy, elemental analysis, electrospray ionization mass spectrometry. The speciation of Cu/NTB in aqueous solution was investigated by potentiometric pH titrations. Their inhibitory effects against human protein tyrosine phosphatase 1B (PTP1B), T-cell protein tyrosine phosphatase (TCPTP), megakaryocyte protein tyrosine phosphatase 2 (PTP-MEG2), srchomology phosphatase 1 (SHP-1) and srchomology phosphatase 2 (SHP-2) were evaluated in vitro. The five copper complexes exhibit potent inhibition against PTP1B, TCPTP and PTP-MEG2 with almost same inhibitory effects with IC₅₀ at submicro molar level and about tenfold weaker inhibition versus SHP-1, but almost no inhibition against SHP-2. Kinetic analysis indicates that they are reversible competitive inhibitors of PTP1B. Fluorescence study on the interaction between PTP1B and complex 2 or 4 suggests that the complexes bind to PTP1B with the formation of a 1:1 complex. The binding constant are about 1.14 × 10⁶ and 1.87 × 10⁶ M⁻¹ at 310 K for 2 and 4, respectively.     

Dinuclear fumarato- and terephthalato-bridged copper(II) complexes: Structural characterization and magnetic properties

The dinuclear dicarboxylato-bridged copper(II) complexes [Cu₂(TPA)₂(μ-tp)](ClO₄)₂ · H₂O (1), [Cu₂(TPA)₂(μ-fum)](ClO₄)₂ · 2H₂O (2) and [Cu₂(pmedien)₂(μ-fum)(H₂O)₂](ClO₄)₂ (3) (tp = terephthalate dianion, fum = fumarate dianion, TPA = tris(2-pyridylmethyl)amine and pmedien = N,N,N′,N″,N″-pentamethyldiethylenetriamine) were synthesized and structurally characterized by X-ray crystallography. The structures of the TPA complexes 1 and 2 consist of μ-tp or μ-fum bridging two Cu(II) centers in a bis(monodentate) bonding fashion. The coordination geometry around the Cu(II) ions in these compounds has a distorted trigonal bipyamidal geometry, TBP with four nitrogen atoms from the TPA ligand and a coordinated oxygen atom supplied by the carboxylate group of the bridged dicarboxylato ligand. Complex 3 has a distorted square pyramidal geometry achieved by the three N-atoms of the pmedien, one fum-carboxylate-oxygen and by an oxygen atom from a coordinated water molecule. The intradimer Cu…Cu distances in these complexes are 11.078(3), 8.663(4) and 9.520(3) Å for 1, 2 and 3, respectively. The electronic spectra of the complexes in aqueous solutions are in complete agreement with the assigned X-ray geometry around the Cu(II) centers. Also, analysis of the infrared spectral data for the ν(COO⁻) stretching frequencies of the tp-carboxalato groups reveals the existence of the bis(mondentate) coordination mode for the bridged dicarboxylato ligands in compounds 1 and 2. The susceptibility measurements at variable temperature over the 2-300 K range are reported. For 1-3, it has been observed slight antiferromagnetic coupling with J values of −0.8, −3.0 and −2.9 cm⁻¹, respectively.     

Dinuclear terephthalato-bridged copper(II) complexes: Syntheses, spectral and structural characterization, and magnetic properties

Herein, we report the syntheses, spectral and structural characterization, and magnetic behavior of four new dinuclear terephthalato-bridged copper(II) complexes with formulae [Cu₂(trpn)₂(μ-tp)](ClO₄)₂ · 2H₂O (1), [Cu₂(aepn)₂(μ-tp)(ClO₄)₂] (2), [Cu₂(Medpt)₂(μ-tp)(H₂O)₂](ClO₄)₂ (3) and [Cu₂(Et₂dien)₂(μ-tp)(H₂O)](ClO₄)₂ (4) where tp = terephthalate dianion, trpn = tris(3-aminopropyl)-amin, aepn = N-(2-aminoethyl)-1,3-propanediamine, Medpt = 3,3′-diamino-N-methyldipropylmine and Et₂dien = N,N-diethyldiethylenetriamine. The structures of these complexes consist of two μ-tp bridging Cu(II) centers in a bis(monodentate) bonding fashion. The coordination geometry of the Cu(II) ions in these compounds may be described as close to square-based pyramid (SP) with severe significant distortion towards trigonal bipyramid (TBP) stereochemistry in 1. The visible spectra of the complexes in aqueous solutions are in complete agreement with the assigned X-ray geometry around the Cu(II) centers. Also, the solid infrared spectral data for the stretching frequencies of the tp-carboxalato groups, the ν(COO⁻) reveals the existence of bis(monodentate) coordination mode for the bridged terephthalate ligand. The susceptibility measurements at variable temperature over the range 2-300 K are reported. Despite the same bonding mode of the tp bridging ligand, there has been observed slight antiferromagnetic coupling for the compounds 1 and 4 with J values of −0.5 and −2.9 cm³ K mol⁻¹, respectively, and very weak ferromagnetic coupling for 2 and 3 with J values of 0.8 and 10.1 cm³ K mol⁻¹, respectively. The magnetic results are discussed in relation to other related μ-terephthalato dinuclear Cu(II) published compounds.     

Dinuclear and mononuclear copper(II) carboxylate complexes with cis-chelating diacids

The synthesis and crystal structures of two new copper complexes with chelating dicarboxylic acids are described. Reaction of copper(II) acetate with diacid H₂L2 (HO₂CC(Me)₂OArOC(Me)₂CO₂H, Ar=1,3-substituted phenyl) gave a bischelate complex (L2)₂Cu₂ · 2MeOH with the normal paddlewheel structure and tilted, trans-oriented chelate rings with skewed conformations. The overall structure was reasonably well reproduced by density functional calculations on (L2)₂Cu₂. Treatment of the product from reaction of Cu₂(OAc)₄ and diacid H₂L3 (Ar=1,3-substituted 2,4-dibromophenyl) with pyridine gave a six-coordinate mononuclear chelate (L3)Py₂Cu · H₂O in which one chelate carboxylate is monodentate, the other is unsymmetrically bidentate, and the pyridines are cis-coordinated.     

Dinuclear ruthenium sawhorse-type complexes containing carboxylato bridges and ferrocenyl substituents: Synthesis and electrochemistry

The ferrocenyl-containing diruthenium complexes [Ru₂(CO)₄(μ₂-η²-OOCFc)₂L₂] (Fc = ferrocenyl, fc = ferrocen-1,1′-diyl; 1: L = NC₅H₄-COOC₆H₄-OC₁₀H₂₁, 2: L = NC₅H₄-COOC₆H₄-OC₁₆H₃₃, 3: L = NC₅H₄-OOC-fc-C₁₂H₂₅) and [Ru₂(CO)₄(μ₂-η²-OOC₆H₅)₂(NC₅H₄-OOC-fc-C₁₂H₂₅)₂] (4) have been synthesized from Ru₃(CO)₁₂, ferrocene carboxylic or benzoic acid and the corresponding pyridine derivative. The synthesis of the new pyridine derivative NC₅H₄-OOC-fc-C₁₂H₂₅ used for the preparation of 3 and 4 is also reported. Complexes 1-4 posses a so-called sawhorse structure consisting of the Ru₂(CO)₄ backbone and two bridging carboxylato ligands, while the coordination sphere around the ruthenium atoms is completed by the pyridine-derived ligands bonded in the axial positions. The electrochemical behavior of 1-4 and their known analogues [Ru₂(CO)₄(μ₂-η²-OOCFc)₂L₂] (5: L = NC₅H₅, 6: L = P(C₆H₅)₃, 7: L = NC₅H₄-OOCFc) has been studied by voltammetry on rotating disc electrode and by cyclic voltammetry.     

Inhibition of the catecholase activity of biomimetic dinuclear copper complexes by kojic acid

The inhibition of the catechol oxidase activity exhibited by three dinuclear copper(II) complexes, derived from different diaminotetrabenzimidazole ligands, by kojic acid [5-hydroxy-2-(hydroxymethyl)-γ-pyrone] has been studied. The catalytic mechanism of the catecholase reaction proceeds in two steps and for both of these inhibition by kojic acid is of competitive type. The inhibitor binds strongly to the dicopper(II) complex in the first step and to the dicopper-dioxygen adduct in the second step, preventing in both cases the binding of the catechol substrate. Binding studies of kojic acid to the dinuclear copper(II) complexes and a series of mononuclear analogs, carried out spectrophotometrically and by NMR, enable us to propose that the inhibitor acts as a bridging ligand between the metal centers in the dicopper(II) catalysts. Received: 23 August 1999 / Accepted: 20 January 2000     

Dinuclear alkoxo-bridged copper(II) coordination polymers: Syntheses, structural and magnetic properties

The alkoxo-bridged dinuclear copper(II) complexes [Cu₂(ap)₂(NO₂)₂] (1), [Cu₂(ap)₂(C₆H₅COO)₂] (2) and [Cu₂(ap)₂μ-1,3-C₆H₄(COO)₂(dmso)₂]·dmso (3) (ap = 3-aminopropanolato and dmso = dimethyl sulfoxide) have been synthesized via self-assembly from copper(II) perchlorate, 3-aminopropanol as main chelating ligand and nitrite and isophthalate anions as spacers and benzoate anion as auxiliary ligand. Complexes 1 and 3 crystallize as 2D and 1D coordination polymers, respectively, and their structures consist of dinuclear [Cu₂(ap)₂]²⁺ units connected with nitrite and isophthalate ligands. The adjacent dinuclear units of 2 and 1D polymers of 3 are further connected by hydrogen bonds resulting in the formation of 2D layers. The variable temperature crystallographic measurements of 1 at 100, 173 and 293 K indicate the static Jahn-Teller distortion with librational disorder in the nitrite group. Experimental magnetic studies showed that complexes 1-3 exhibit strong antiferromagnetic couplings. The values of the magnetic exchange coupling constant for 1-3 are well reproduced by the theoretical calculations.     

Dinuclear silver(I) complexes of 24-membered bibracchial tetraimine Schiff base macrocycles derived from 2,5-diformylthiophene

The cyclocondensation of 2,5-diformylthiophene and the amines N,N-bis-(2-aminoethyl)-2-phenylethylamine, N,N-bis-(2aminoethyl)-t-butyl-amine and N,N-bis-(2-aminoethyl)-t-butyl-amine in the presence of silver(I) salts yields homodinuclear bibracchial tetraimine Schiff base macrocyclic complexes. The structures of two such complexes are also reported. The complex Ag₂L⁴(NO₃)(PF₆) (2) crystallises in the triclinic space group , No. 2) and has unit-cell dimensions a = 12.834(6), B = 13.183(6), C = 14.588(7) Å, = 64.86(4), β = 79.77(4), γ = 69.44(3)° with Z = 2; there is a monodentate and singly bridging nitrate anion present and the Ag---Ag separation is 4.161 Å. The complex Ag₂L⁴(CH₃CN)₂(BF₄)₂·CH₃CN (9) crystallises in the triclinic space group , No. 2) and has unit-cell dimensions a = 9.297(4), B = 12.985(3), C = 21.770(5) Å, = 91.570(10), β = 92.33(3), γ = 97.92(3) ° with Z = 2; there is a strongly bonded acetonitrile molecule coordinated to each silver atom and the Ag---Ag separation is 4.920 Å.     

Dinuclear terephthalato-bridged nickel(II) complexes. Structural characterization and magnetic properties

The dinuclear terephthalato-bridged nickel(II) complexes [Ni₂(cyclen)₂(μ-tp)](ClO₄)₂ (1) [Ni₂(trpn)₂(μ-tp)(H₂O)₂](ClO₄)₂ (2) and [Ni₂(3,3,3-tet)₂(μ-tp)(H₂O)₂](ClO₄)₂ · 2H₂O (3), where tp = terephthalate dianion, cyclen = 1,4,7,10-tetraazacyclododecane, trpn = tris(3-aminopropyl)amine and 3,3,3-tet = 1,5,9,13-tetraazatridecane, were synthesized and structurally characterized by X-ray crystallography. Their magnetic susceptibilities were also determined at variable temperatures over the range 2-300 K. The structures of these complexes consist of μ-tp bridging two Ni(II) centers in a bis(bidentate) bonding fashion in 1 and in bis(monodentate) bonding fashion in 2 and 3. The coordination geometry around the Ni(II) ions in these compounds has a distorted octahedral geometry with four nitrogen atoms from the amine ligand (cyclen, trpn or 3,3,3-tet) and two coordinated oxygen atoms supplied by the chelated carboxylate group of the bridged terephthalate ligand in 1, and by one tp-carboxylate-oxygen in 2 and 3. The sixth coordination site in the last two complexes 2 and 3 is achieved via an oxygen atom from a coordinated water molecule. The intradimer Ni…Ni distances in these complexes are 10.740, 11.428 and 11.537 Å for 1, 2 and 3, respectively. The electronic spectra of the complexes in aqueous solutions are in complete agreement with the assigned X-ray geometry around the Ni(II) centers. Also, the analysis of the infrared spectral data for the ν(COO⁻) stretching frequencies of the tp-carboxalato groups reveals the existence of the bis(bidentate) and bis(monodentate) coordination modes for the bridged terephthalate ligand in 1, 2 and 3, respectively. Despite the different coordination modes of the tp bridging ligand in these complexes, they all exhibit very weak antiferromagnetic coupling. The coupling constants J were found to be −2.2, −0.6 and −1.5 cm³ K mol⁻¹ for the complexes 1, 2 and 3, respectively. The structural and magnetic results of 1-3 are discussed in relation to the other related published μ-terephthalato dinuclear Ni(II) compounds.     

Dinuclear gold(III) pyrazolato complexes - Synthesis, structural characterization and transformation to their trinuclear gold(I) and gold(I/III) analogues

The reaction of AuCl₃py with Na(pz∗) (pz∗ = pyrazolato, or substituted pyrazolato anion) yields stable dinuclear [cis-Au^IIICl₂(μ-pz∗)]₂ complexes. In the presence of a base, the latter undergo reduction with concomitant transformation of the dinuclear -structure to trinuclear Au^I, Au^III (containing trans Au^IIICl₂-centres) and species.     

Synthesis, characterization, and protein tyrosine phosphatases inhibition activities of oxovanadium(IV) complexes with Schiff base and polypyridyl derivatives

Seven new mixed-ligand vanadyl complexes, [V^IVO(5-Br-SAA)(NN)] and [V^IVO(2-OH-NAA)(NN)] (1-7) (5-Br-SAA for 5-bromosalicylidene anthranilic acid, 2-OH-NAA for 2-hydroxy-1-naphthaldehyde anthranilic acid and NN for N,N′-donor heterocyclic base, namely, 2,2′-bipyridine (bpy, 1 and 5), 1,10-phenanthroline (phen, 2 and 6), dipyrido[3,2-d:2′,3′-f]quinoxaline (dpq, 3 and 7), dipyrido[3,2-a:2′,3′-c]phenazine (dppz, 4)), were synthesized and characterized. X-ray crystal structure of [V^IVO(5-Br-SAA)(phen)] revealed a distorted octahedral geometry with the Schiff base ligand coordinated in a tridentate ONO-fashion and the phenanthroline ligand in a bidentate fashion. Density-functional theory (DFT) calculations suggest a similar structure and the same coordination mode for all the other oxovanadium complexes synthesized. Biochemical assays demonstrate that the mixed-ligand oxovanadium(IV) complexes are potent inhibitors of protein tyrosine phosphatase 1B (PTP1B), with IC₅₀ values approximately 41-75 nM. Kinetics assays suggest that the complexes inhibit PTP1B in a competitive manner. Notably, they had moderate selectivity of PTP1B over T-cell protein tyrosine phosphatase (TCPTP) (about 2-fold) and good selectivity over Src homology phosphatase 1 (SHP-1) (about 4∼7-fold). Thus, these mixed-ligand complexes represent a promising class of PTP1B inhibitors for future development as anti-diabetic agents.     

Dinuclear macrocyclic polyamine zinc(II) complexes linked with flexible spacers: synthesis, characterization, and DNA cleavage

Dinuclear macrocyclic polyamine zinc(II) complexes, which have two cyclen groups linked by flexible spacers, have been synthesized as DNA cleavage agents. The structures of these new dinuclear complexes are consistent with the data obtained from elemental analysis, MS and ¹H NMR spectroscopy. The catalytic activity of these dinuclear complexes on DNA cleavage was studied. The results showed that the dinuclear zinc(II) complexes can catalyze the cleavage of supercoiled DNA (pUC 19 plasmid DNA) (Form I) under physiological conditions to produce selectively nicked DNA (Form II).     

Squarato-metal(II) complexes. 1: Structural and magnetic characterization of squarato-bridged dinuclear nickel(II) and copper(II) complexes

A new series of dinuclear squarato-bridged nickel(II) and copper(II) complexes [Ni₂(2,3,2-tet)₂(μ_1,3-C₄O₄)(H₂O)₂](ClO₄)₂ (1), [Ni₂(aepn)₂(μ_1,3-C₄O₄)(H₂O)₂](ClO₄)₂ (2), [Cu₂(pmedien)₂(μ_1,3-C₄O₄)(H₂O)₂](ClO₄)₂.4H₂O (3) and [Cu₂(DPA)₂(μ_1,2-C₄O₄)(H₂O)₂](ClO₄)₂ (4) where is the dianion of 3,4-dihydroxycyclobut-3-en-1,2-dione (squaric acid), 2,3,2-tet = 1,4,8,11-tetraazaundecane, aepn = N-(2-aminoethyl)-1,3-propanediamine, pmedien = N,N,N′,N″,N″-pentamethyldiethylenetriamine and DPA = di(2-pyridylmethyl)amine were synthesized and structurally characterized by X-ray crystallography. The spectral and structural characterization as well as the magnetic behaviour of these complexes is reported. In this series, structures consist of the groups as counter ions and the bridging the two M(II) centers in a μ-1,3- (1-3) and in a μ-1,2-bis(monodentate) (4) bonding fashions. The coordination geometry around the Ni(II) ions in 1 and 2 is six-coordinate with distorted octahedral environment achieved by N atoms of the amines and by one or two oxygen atoms from coordinated water molecules, respectively. In the Cu(II) complexes 3 and 4, a distorted square pyramidal geometry is achieved by the three N-atoms of the aepn or DPA and by an oxygen atom from a coordinated water molecule. The electronic spectra of the complexes in aqueous solutions are in complete agreement with the assigned X-ray geometry around the M(II) centers. The complexes show weak antiferromagnetic coupling with ∣J∣ = 1.8-4.2 cm⁻¹ in the μ-1,3- bridged squarato compounds 1-3, and J = −16.1 cm⁻¹ in the corresponding μ-1,2- bridged squarato complex 4. The magnetic properties are discussed in relation to the structural data.     

Identification of chebulinic acid as a dual targeting inhibitor of protein tyrosine phosphatases relevant to insulin resistance

Natural products as antidiabetic agents have been shown to stimulate insulin signaling via the inhibition of the protein tyrosine phosphatases relevant to insulin resistance. Previously, we have identified PTPN9 and DUSP9 as potential antidiabetic targets and a multi-targeting natural product thereof. In this study, knockdown of PTPN11 increased AMPK phosphorylation in differentiated C2C12 muscle cells by 3.8 fold, indicating that PTPN11 could be an antidiabetic target. Screening of a library of 658 natural products against PTPN9, DUSP9, or PTPN11 identified chebulinic acid (CA) as a strong allosteric inhibitor with a slow cooperative binding to PTPN9 (IC₅₀ = 34 nM) and PTPN11 (IC₅₀ = 37 nM), suggesting that it would be a potential antidiabetic candidate. Furthermore, CA stimulated glucose uptake and resulted in increased AMP-activated protein kinase (AMPK) phosphorylation. Taken together, we demonstrated that CA increased glucose uptake as a dual inhibitor of PTPN9 and PTPN11 through activation of the AMPK signaling pathway. These results strongly suggest that CA could be used as a potential therapeutic candidate for the treatment of type 2 diabetes.     

Dinuclear copper(II) complexes containing 6-(benzylamino)purines as bridging ligands: Synthesis, characterization, and in vitro and in vivo antioxidant activities

A series of dinuclear copper(II) complexes involving 6-(benzylamino)purine derivatives, (HL_n), as bridging ligands were synthesized, characterized and tested for both their in vitro and in vivo antioxidant activities. Based on results of elemental analyses, temperature dependence of magnetic susceptibility measurements, UV-vis, FTIR, EPR, NMR and MALDI-TOF mass spectroscopy, conductivity measurements and thermal analyses, the complexes with general compositions of [Cu₂(μ-HL_n)₄Cl₂]Cl₂ · 2H₂O (1-4) and [Cu₂(μ-HL_n)₂(μ-Cl)₂Cl₂] (5-7) were prepared {where n = 1-4; HL₁ = 6-[(2-methoxybenzyl)amino]purine, HL₂ = 6-[(4-methoxybenzyl)amino]purine, HL₃ = 6-[(2,3-dimethoxybenzyl)amino]purine and HL₄ = 6-[(3,4-dimethoxybenzyl)amino]purine}. In the case of complexes 2, 3, 5 and 7, the antioxidant activities were studied by both in vitro {superoxide dismutase-mimic (SOD-mimic) activity} and in vivo {cytoprotective effect against the alloxan-induced diabetes (antidiabetic activity)} methods. The obtained IC₅₀ value of the SOD-mimic activity for the complex 5 (IC₅₀ = 0.253 μM) was shown to be even better than that of the native bovine Cu,Zn-SOD enzyme (IC₅₀ = 0.480 μM), used as a standard. As for the antidiabetic activity, the pretreatment of mice with complexes 3 and 7 led to the complete elimination of cytotoxic attack of alloxan and its free radical metabolites, used as a diabetogenic agent. The cytoprotective effect of these compounds was proved by the preservation of the initial blood glucose levels of the pretreated animals, as against the untreated control group.     

Dinuclear Rh(II) complexes with one polypyridyl ligand, structure, properties and antitumor activity

Rhodium(II) complexes [Rh₂(μ-OAc)₂(OAc)(bpy)(H₂O)₂]PF₆ (1), [Rh₂(μ-OAc)₂(OAc)(phen)(H₂O)₂](PF₆)·H₂O (2), [Rh₂(μ-OOCCH₃)₃(OOCCH₃)(phen)] (3) and [Rh₂(μ-O₂CCH₃)₃(O₂CCH₃)(Ph₂phen)] (4) (Ph₂phen = 4,7-diphenyl-1,10-phenanthroline) have been synthesized and characterized by means of NMR, IR and UV-Vis spectroscopic methods. X-ray structure of complex 4·1.5(CH₃COCH₃) has been determined and its geometry and electronic structure has been elucidated using OPBE and B3LYP DFT methods. The compounds are active cytostatic agents against tumor cells.     

Cytotoxic dinuclear titanium-salan complexes: structural and biological characterization

Controlled hydrolysis of donor-substituted titanium-salan complexes led to the formation of well-defined dinuclear complexes. Structure determination by means of X-ray and NMR-studies revealed the presence of a single μ-oxo bridge and one labile alkoxide ligand per titanium center. Concomitant cytotoxicity assays of the isolated dinuclear complexes showed cytotoxicities in the low micro-molar region, surpassing in this respect even their monomeric ancestors, thus making them possible highly active metabolites of titanium-salan anti-cancer drugs.     

Osteoblastic protein tyrosine phosphatases inhibition and connexin 43 phosphorylation by alendronate

Bisphosphonates (BPs), potent inhibitors of bone resorption which inhibit osteoclasts, have also been shown to act on osteocytes and osteoblasts preventing apoptosis via connexin (Cx) 43 hemichannels and activating the extracellular signal regulated kinases ERKs. We previously demonstrated the presence of a saturable, specific and high affinity binding site for alendronate (ALN) in osteoblastic cells which express Cx43. However, cells lacking Cx43 also bound BPs. Herein we show that bound [³H]-alendronate is displaced by phosphatase substrates. Moreover, similar to Na₃VO₄, ALN inhibited the activity of transmembrane and cytoplasmic PTPs, pointing out the catalytic domain of phosphatases as a putative BP target. In addition, anti-phospho-tyrosine immunoblot analysis revealed that ALN stimulates tyrosine phosphorylation of several proteins of whole cell lysates, among which the major targets of the BP could be immunochemically identified as Cx43. Additionally, the transmembrane receptor-like PTPs, RPTPµ and RPTPα, as well as the cytoplasmic PTP1B, are highly expressed in ROS 17/2.8 cells. Furthermore, we evidenced that Cx43 interacts with RPTPµ in ROS 17/2.8 and ALN decreases their association. These results support the hypothesis that BPs bind and inhibit PTPs associated to Cx43 or not, which would lead to the activation of signaling pathways in osteoblasts.     

Effect of pyrazole-substitution on the structure and nuclearity of Cu(II)-pyrazolato complexes

Trinuclear Cu(II)-pyrazolates of the general formula (Bu₄N)₂[Cu₃(μ₃-Cl)₂(μ-4-R-pz)₃Cl₃] (pz=pyrazolato anion, R=Cl, Br, I, Me), 1-4, have been prepared and characterized by X-ray diffraction and/or ¹H NMR, IR, UV-Vis spectroscopy and elemental analysis. Their structure and spectroscopic properties match the ones of the parent unsubstituted complex (Bu₄N)₂[Cu₃(μ₃-Cl)₂(μ-pz)₃Cl₃], indicating that 4-substitution of the pyrazole ligands with halogen or methyl groups does not induce structural variation. In contrast, dinuclear complexes (Bu₄N)₄[Cu₂(μ-3-Me-pz)₂Cl₄]Cl₂ · 4H₂O, Cu₂(μ-Cl)(μ-3,5-Me₂-pz)(3,5-Me₂-pzH)₄Cl₂, Cu₂(μ-Cl)(μ-OH)(3-Me-5-Ph-pzH)₄Cl₂ · 3-Me-5-Ph-pzH and Cu₂(μ-Cl)₂(3,5-Ph₂-pzH)₄Cl₂, 5-8, have been prepared with 3- and 3,5-substituted pyrazoles by the same or similar synthetic protocols.     

Identification of novel imidazole flavonoids as potent and selective inhibitors of protein tyrosine phosphatase

A series of imidazole flavonoids as new type of protein tyrosine phosphatase inhibitors were synthesized and characterized. Most of them gave potent protein phosphatase 1B (PTP1B) inhibitory activities. Especially, compound 11a could effectively inhibit PTP1B with an IC₅₀ value of 0.63 μM accompanied with high selectivity ratio (9.5-fold) over T-cell protein tyrosine phosphatase (TCPTP). This compound is cell permeable with relatively low cytotoxicity. The high binding affinity and selectivity was disclosed by molecular modeling and dynamics studies. The structural features essential for activity were confirmed by quantum chemical studies.